0001819114-23-000001.txt : 20230707 0001819114-23-000001.hdr.sgml : 20230707 20230707090213 ACCESSION NUMBER: 0001819114-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230707 DATE AS OF CHANGE: 20230707 EFFECTIVENESS DATE: 20230707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Optimeos Life Sciences, Inc. CENTRAL INDEX KEY: 0001819114 IRS NUMBER: 814242793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486138 FILM NUMBER: 231075352 BUSINESS ADDRESS: STREET 1: 174 NASSAU STREET, SUITE 334 CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: 609-658-9839 MAIL ADDRESS: STREET 1: 174 NASSAU STREET, SUITE 334 CITY: PRINCETON STATE: NJ ZIP: 08542 D 1 primary_doc.xml X0708 D LIVE 0001819114 Optimeos Life Sciences, Inc. 174 NASSAU STREET, SUITE 334 PRINCETON NJ NEW JERSEY 08542 609-658-9839 DELAWARE None None Corporation true Shahram Hejazi, PhD 174 Nassau Street, Suite 334 Princeton NJ NEW JERSEY 08542 Executive Officer Director Robert K. Prud'homme, PhD 174 Nassau Street, Suite 334 Princeton NJ NEW JERSEY 08542 Director Jason Smith, PhD 174 Nassau Street, Suite 334 Princeton NJ NEW JERSEY 08542 Director Biotechnology Decline to Disclose 06b false 2023-06-26 false true true Equity to be issued upon conversion of previously issued convertible securities false 0 5000000 1875004 3124996 false 4 0 0 0 false Optimeos Life Sciences, Inc. Shahram Hejazi Shahram Hejazi President and CEO 2023-07-07